Article
CCL20 and CD8A as diagnostic biomarkers for HBV infection-induced hepatic fibrosis development, including immune infiltration in HBV-LF
2022-09-16
Abstract excerpt
<h4>Background: </h4> Histologically, hepatic fibrosis still occures progressively in chronic hepatitis B patients, even if HBV-DNA is negative or undetectable. The diagnosis of hepatic fibrosis is beneficial to control the development of it or promote the reversal. Liver biopsy is a traumatic diagnosis, which is the gold standard of diagnosis at present. The diagnosis of hepatic fibrosis badly needs diagnostic bi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7c25db67-fd8d-5ac2-a3ae-ea6591c54d2a
- DOI
- 10.21203/rs.3.rs-2042069/v1
